Doppler ultrasound assessment of splanchnic perfusion and heart rate for the detection of necrotizing enterocolitis
link.springer.com shows its articles on its own site.
Read the article on link.springer.com ↗Article · Feb 2021 · 1 min read
In brief
In brief
Mouse model study demonstrates that Doppler ultrasound can detect reduced superior mesenteric artery flow in advanced necrotizing enterocolitis, occurring alongside increased heart rate and intestinal hypoperfusion. Findings suggest Doppler imaging may serve as a non-invasive monitoring tool for NEC progression in neonates.
Written by the GCMD Library team from the article.
Abstract
Purpose
Monitoring disease progression is crucial to improve the outcome of necrotizing enterocolitis (NEC). A previous study indicates that intestinal wall flow velocity was reduced in NEC pups from the initial stages of the disease. This study aims to investigate whether splanchnic perfusion via the superior mesenteric artery (SMA) (i) is altered during NEC development and (ii) can be used as a monitoring tool to assess disease progression.
Methods
NEC was induced in C57BL/6 mice via gavage feeding of formula, hypoxia, and oral lipopolysaccharide, from postnatal day 5 (P5) to P9 (AUP: 32,238). Breastfed littermates served as controls. Doppler ultrasound (U/S) of bowel loops was performed daily. Intestinal wall perfusion was calculated as average flow velocity (mm/s) of multiple abdominal regions. Groups were compared using one-way ANOVA.
Results
The SMA flow velocity was not altered during the initial stage of NEC development, but become significantly reduced at P8 when the intestinal disease was more advanced. These changes occurred concomitantly with an increase in heart rate.
Conclusions
NEC is associated with intestinal hypo-perfusion at the periphery and flow in the SMA is reduced during the later stages of disease indicating the presence of intestinal epithelium damage. This study contributes to understanding NEC pathophysiology and illustrates the value of Doppler U/S in monitoring disease progression.